<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.cardiothoracicsurgery.org/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Cardiothoracic Surgery - Latest Articles</title>
        <link>http://www.cardiothoracicsurgery.org</link>
        <description>The latest research articles published by Journal of Cardiothoracic Surgery</description>
        <dc:date>2010-03-10T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/10" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/9" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/8" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/7" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/6" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/5" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/4" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/3" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/2" />
                                <rdf:li rdf:resource="http://www.cardiothoracicsurgery.org/content/5/1/1" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/10">
        <title>Intrathoracic fire during preparation of the left internal thoracic artery for coronary artery bypass grafting</title>
        <description>A surgical fire is a serious complication not previously described in the literature with regard to the thoracic cavity. We report a case in which an intrathoracic fire developed following an air leak combined with high pressure oxygen ventilation in a patient with severe chronic obstructive pulmonary disease. The patient presented to our institution with diffuse coronary artery disease and angina pectoris. He was treated with coronary artery bypass graft surgery, including left internal thoracic artery harvesting. Additionally to this rare presentation of an intrathoracic fire, a brief review of surgical fires is included to this paper.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/10</link>
                <dc:creator>Martin Friedrich</dc:creator>
                <dc:creator>Theodor Tirilomis</dc:creator>
                <dc:creator>Jan Schmitto</dc:creator>
                <dc:creator>Aron Popov</dc:creator>
                <dc:creator>Suyog Mokashi</dc:creator>
                <dc:creator>Marc Hinterthaner</dc:creator>
                <dc:creator>Gunnar Hanekop</dc:creator>
                <dc:creator>Paul Zwaka</dc:creator>
                <dc:creator>Friedrich Schoendube</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:10</dc:source>
        <dc:date>2010-03-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-10</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2010-03-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/9">
        <title>Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction</title>
        <description>This the case of a 63 year-old man with end-stage renal disease (on chronic hemodialysis), unstable angina and significantly impaired myocardial contractility with low left ventricular ejection fraction, who underwent off-pump one vessel coronary bypass surgery. Combined continuous levosimendan and norepinephrine infusion (at 0.07 mug/kg/min and 0.05 mug/kg/min respectively) started immediately after anesthesia induction and continued for 24 hours. The levosimendan / norepinephrine combination helped maintain an appropriate hemodynamic profile, thereby contributing to uneventful completion of surgery and postoperative hemodynamic stability. Although levosimendan is considered contraindicated in ESRD patients, this case report suggests that combined perioperative levosimendan / norepinephrine administration can be useful in carefully selected hemodialysis patients with impaired myocardial contractility and ongoing myocardial ischemia, who undergo off-pump myocardial revascularization surgery.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/9</link>
                <dc:creator>Georgios Papadopoulos</dc:creator>
                <dc:creator>Nikolaos Baikoussis</dc:creator>
                <dc:creator>Petros Tzimas</dc:creator>
                <dc:creator>Stavros Siminelakis</dc:creator>
                <dc:creator>Menelaos Karanikolas</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:9</dc:source>
        <dc:date>2010-03-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-9</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2010-03-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/8">
        <title>Preoperative statin is associated with decreased operative mortality in high risk coronary artery bypass patients
</title>
        <description>Background:
Statins are widely prescribed to patients with atherosclerosis. A retrospective database analysis was used to examine the role of preoperative statin use in hospital mortality, for patients undergoing isolated coronary artery bypass grafting (CABG.)
Methods:
The study population comprised 2377 patients who had isolated CABG at Allegheny General Hospital between 2000 and 2004.  Mean age of the patients was 65 +/- 11 years (range 27 to 92 years). 1594 (67%) were male, 5% had previous open heart procedures, and 4% had emergency surgery. 1004 patients (42%) were being treated with a statin at the time of admission. Univariate, bivariate (Chi2, Fisher&apos;s Exact and Student&apos;s t-tests) and multivariate (stepwise linear regression) analyses were used to evaluate the association of statin use with mortality following CABG.
Results:
Annual prevalence of preoperative statin use was similar over the study period and averaged 40%.  Preoperative clinical risk assessment demonstrated a 2% risk of mortality in both the statin and non-statin groups. Operative mortality was 2.4% for all patients, 1.7% for statin users and 2.8% for non-statin users (p &lt; 0.07). Using multivariate analysis, lack of statin use was found to be an independent predictor of mortality in high-risk patients (n = 245, 12.9% vs. 5.6%, p &lt; 0.05).
Conclusions:
Between 2000 and 2004 less than 50% of patients at this institution were receiving statins before admission for isolated CABG.  A retrospective analysis of this cohort provides evidence that preoperative statin use is associated with lower operative mortality in high-risk patients.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/8</link>
                <dc:creator>James Magovern</dc:creator>
                <dc:creator>Robert Moraca</dc:creator>
                <dc:creator>Stephen Bailey</dc:creator>
                <dc:creator>David Dean</dc:creator>
                <dc:creator>Kathleen Simpson</dc:creator>
                <dc:creator>Thomas Maher</dc:creator>
                <dc:creator>Daniel Benckart</dc:creator>
                <dc:creator>George Magovern</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:8</dc:source>
        <dc:date>2010-02-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-8</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2010-02-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/7">
        <title>Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial</title>
        <description>Background:
Cardiac surgery is a major consumer of blood products, and hemodilution increases transfusion requirements during cardiac surgery under CPB. As intraoperative parenteral fluids contribute to hemodilution, we evaluated the hypothesis that intraoperative fluid restriction reduces packed red-cell (PRC) use, especially in transfusion-prone adults undergoing elective cardiac surgery.
Methods:
192 patients were randomly assigned to restrictive (group A, 100pts), or liberal (group B, 92pts) intraoperative intravenous fluid administration. All operations were conducted by the same team (same surgeon and perfusionist). After anesthesia induction, intravenous fluids were turned off in Group A (fluid restriction) patients, who only received fluids if directed by protocol. In contrast, intravenous fluid administration was unrestricted in group B. Transfusion decisions were made by the attending anesthesiologist, based on identical transfusion guidelines for both groups.
Results:
137 of 192 patients received 289 PRC units in total. Age, sex, weight, height, BMI, BSA, LVEF, CPB duration and surgery duration did not differ between groups. Fluid balance was less positive in Group A. Fewer group A patients (62/100) required transfusion compared to group B (75/92, p&lt;0.04). Group A patients received fewer PRC units (113) compared to group B (176; p&lt;0.0001). Intraoperatively, the number of transfused units and transfused patients was lower in group A (31u in 19pts vs. 111u in 62pts; p&lt;0.001). Transfusions in ICU did not differ significantly between groups. Transfused patients had higher age, lower weight, height, BSA and preoperative hematocrit, but no difference in BMI or discharge hematocrit. Group B (p&lt;0.005) and female gender (p&lt;0.001) were associated with higher transfusion probability. Logistic regression identified group and preoperative hematocrit as significant predictors of transfusion.
Conclusions:
Our data suggest that fluid restriction reduces intraoperative PRC transfusions without significantly increasing postoperative transfusions in cardiac surgery; this effect is more pronounced in transfusion-prone patients.Trial registration NCT00600704, at the United States National Institutes of Health.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/7</link>
                <dc:creator>George Vretzakis</dc:creator>
                <dc:creator>Athina Kleitsaki</dc:creator>
                <dc:creator>Konstantinos Stamoulis</dc:creator>
                <dc:creator>Metaxia Bareka</dc:creator>
                <dc:creator>Stauroula Georgopoulou</dc:creator>
                <dc:creator>Menelaos Karanikolas</dc:creator>
                <dc:creator>Athanasios Giannoukas</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:7</dc:source>
        <dc:date>2010-02-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-7</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2010-02-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/6">
        <title>&quot;The non-ischemic repair&quot; as a safe alternative method for repair of anterior post-infarction VSD</title>
        <description>Patient&apos;s myocardium with post-infarction ventricular septum defect (VSD) is characterized by severe dysfunction. The &quot;additive ischemia&quot; caused by the operating process of cross-clamp ischemia and reperfusion injury, has a significant aggravation to the myocardium and overall negative impact to patient&apos;s outcome. We present a useful, safe and advantageous methodology in order to abolish &quot;the toxic phase&quot; of ischemia-reperfusion which is adopted by most as the &quot;classic repair method&quot; of myocardial protection. This abolition is in our opinion, particularly beneficial in order to reverse postoperatively the Low Cardiac Output Syndrome (LOS) and achieve better short and long term results. By using this method we avoid the aortic occlusion, the use of systematic hypothermia and any cardioplegic arrest. Furthermore, the total cardio-pulmonary bypass (CPB) time is significantly reduced, tissue debridement and stitching is much easier and safer. We think the method is applicable for every anterior and apical case of post-infarction septum rupture. After application of method in 3 patients with anterior post-myocardial infarction VSD, we are convinced that the patient will have a better postoperative haemodynamic condition and therefore a better outcome.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/6</link>
                <dc:creator>Efstratios Apostolakis</dc:creator>
                <dc:creator>Antonios Kallikourdis</dc:creator>
                <dc:creator>Nikolaos Baikoussis</dc:creator>
                <dc:creator>Panagiotis Dedeilias</dc:creator>
                <dc:creator>Dimitrios Dougenis</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:6</dc:source>
        <dc:date>2010-02-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-6</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2010-02-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/5">
        <title>Microembolic signals and strategy to prevent gas embolism during extracorporeal membrane oxygenation </title>
        <description>Background:
Extracorporeal membrane oxygenation (ECMO) supplies systemic blood perfusion and gas exchange in patients with cardiopulmonary failure. The current literature lacks of papers reporting the possible risks of microembolism among the complications of this treatment.In this study we present our preliminary experience on brain blood flow velocity and emboli detection through the transcranial Doppler monitoring during ECMO.
Methods:
Six patients suffering of heart failure, four after cardiac surgery and two after cardiopulmonary resuscitation were treated with ECMO and submitted to transcranial doppler monitoring to accomplish the neurophysiological evaluation for coma.Four patients had a full extracorporeal flow supply while in the remaining two patients the support was maintained 50% in respect to normal demand.All patients had a bilateral transcranial brain blood flow monitoring for 15 minutes during the first clinical evaluation.
Results:
Microembolic signals were detected only in patients with the full extracorporeal blood flow supply due to air embolism.
Conclusions:
We established that the microembolic load depends on gas embolism from the central venous lines and on the level of blood flow assistance.The gas microemboli that enter in the blood circulation and in the extracorporeal circuits are not removed by the membrane oxygenator filter.Maximum care is required in drugs and fluid infusion of this kind of patients as a possible source of microemboli. This harmful phenomenon may be overcome adding an air filter device to the intravenous catheters.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/5</link>
                <dc:creator>Paolo Zanatta</dc:creator>
                <dc:creator>Alessandro Forti</dc:creator>
                <dc:creator>Enrico Bosco</dc:creator>
                <dc:creator>Loris Salvador</dc:creator>
                <dc:creator>Maurizio Borsato</dc:creator>
                <dc:creator>Fabrizio Baldanzi</dc:creator>
                <dc:creator>Carolina Longo</dc:creator>
                <dc:creator>Carlo Sorbara</dc:creator>
                <dc:creator>Pierluigi Longatti</dc:creator>
                <dc:creator>Carlo Valfre</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:5</dc:source>
        <dc:date>2010-02-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-5</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2010-02-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/4">
        <title>Acute Complex Type A Dissection associated with peripheral malperfusion syndrome treated with a staged approach guided by lactate levels</title>
        <description>Acute type A aortic dissection can be complicated by visceral malperfusion and is associated with a significant surgical morbidity and mortality. We describe a case of successful management of a complex acute type A dissection with mesenteric and lower limb ischemia treated with endovascular thoracic stenting and femoro-femoral crossover bypass grafting followed by aortic arch repair. To accomplish this, we applied a staged therapeutic approach using serial lactate measurements to assess the adequacy of peripheral perfusion and metabolic status prior to surgical repair of the proximal dissection.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/4</link>
                <dc:creator>Amna Suliman</dc:creator>
                <dc:creator>Michael Dialynas</dc:creator>
                <dc:creator>Hutan Ashrafian</dc:creator>
                <dc:creator>Colin Bicknell</dc:creator>
                <dc:creator>Maziar Mireskandari</dc:creator>
                <dc:creator>Mohamad Hamady</dc:creator>
                <dc:creator>Thanos Athanasiou</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:4</dc:source>
        <dc:date>2010-01-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-4</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2010-01-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/3">
        <title>Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies </title>
        <description>Background:
After coronary artery bypass grafting ischemia/reperfusion injury inducing cardiomyocyte apoptosis may occur. This surgery-related inflammatory reaction appears to be of extreme complexity with regard to its molecular, cellular and tissue mechanisms and many studies have been performed on animal models. However, finding retrieved from animal studies were only partially confirmed in humans. To investigate this phenomenon and to evaluate possible therapies in vitro, adequate human cardiomyocyte models are required. We established a tissue model of human cardiomyocytes preserving the complex tissue environment. To our knowledge human cardiac tissue has not been investigated in an experimental setup mimicking extracorporeal circulation just in accordance to clinical routine, yet.
Methods:
Cardiac biopsies were retrieved from the right auricle of patients undergoing elective coronary artery bypass grafting before cardiopulmonary bypass. The extracorporeal circulation was simulated by submitting the biopsies to varied conditions simulating cardioplegia (cp) and reperfusion (rep) in a microperfusion chamber. Cp/rep time sets were 20/7, 40/13 and 60/20 min. For analyses of the calcium homoeostasis the fluorescent calcium ion indicator FURA-2 and for apoptosis detection PARP-1 cleavage immunostaining were employed. Further the anti-apoptotic effect of carvedilol [10 &#956;M] was investigated by adding into the perfusate.
Results:
Viable cardiomyocytes presented an intact calcium homoeostasis under physiologic conditions. Following cardioplegia and reperfusion a time-dependent elevation of cytosolic calcium as a sign of disarrangement of the calcium homoeostasis occurred. PARP-1 cleavage also showed a time-dependence whereas reperfusion had the highest impact on apoptosis. Cardioplegia and carvedilol could reduce apoptosis significantly, lowering it between 60-70% (p &lt; 0.05).
Conclusions:
Our human cardiac preparation served as a reliable cellular model tool to study apoptosis in vitro. Decisively cardiac tissue from the right auricle can be easily obtained at nearly every cardiac operation avoiding biopsying of the myocardium or even experiments on animals.The apoptotic damage induced by the ischemia/reperfusion stimulus could be significantly reduced by the cold crystalloid cardioplegia. The additional treatment of cardiomyocytes with a non-selective &#946;-blocker, carvedilol had even a significantly higher reduction of apoptotis.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/3</link>
                <dc:creator>Engin Usta</dc:creator>
                <dc:creator>Mirijam Renovanz</dc:creator>
                <dc:creator>Migdat Mustafi</dc:creator>
                <dc:creator>Gerhard Ziemer</dc:creator>
                <dc:creator>Hermann Aebert</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:3</dc:source>
        <dc:date>2010-01-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-3</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-01-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/2">
        <title>Flexible bronchoscopic management of benign tracheal stenosis: long term follow-up of 115 patients</title>
        <description>Background:
Management of benign tracheal stenosis (BTS) varies with the type and extent of the disease and influenced by the patient&apos;s age and general health status, hence we sought to investigate the long-term outcome of patients with BTS that underwent minimally invasive bronchoscopic treatment.
Methods:
Patients with symptomatic BTS were treated with flexible bronchoscopy therapeutic modalities that included the following: balloon dilatation, laser photo-resection, self-expanding metal stent placement, and High-dose rate endobronchial brachytherapy used in cases of refractory stent-related granulation tissue formation.
Results:
A total of 115 patients with BTS and various cardiac and respiratory co-morbidities with a mean age of 61 (range 40-88) 
 were treated between January 2001 and January 2009. The underlining etiologies for BTS were post - endotracheal intubation (N = 76) post-tracheostomy (N = 30), Wegener&apos;s granulomatosis (N = 2), sarcoidosis (N = 2), amyloidosis (N = 2) and idiopathic BTS (N = 3). The modalities used were: balloon dilatation and laser treatment (N = 98). Stent was placed in 33 patients of whom 28 also underwent brachytherapy. Complications were minor and mostly included granulation tissue formation. The overall success rate was 87%. Over a median follow-up of 51 months (range 10-100 months), 30 patients (26%) died, mostly due to exacerbation of their underlying conditions.
Conclusions:
BTS in elderly patients with co-morbidities can be safely and effectively treated by flexible bronchoscopic treatment modalities. The use of HDR brachytherapy to treat granulation tissue formation following successful airway restoration is promising.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/2</link>
                <dc:creator>Nader Abdel Rahman</dc:creator>
                <dc:creator>Oren Fruchter</dc:creator>
                <dc:creator>David Shitrit</dc:creator>
                <dc:creator>Benjamin Fox</dc:creator>
                <dc:creator>Mordechai Kramer</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:2</dc:source>
        <dc:date>2010-01-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-2</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-01-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.cardiothoracicsurgery.org/content/5/1/1">
        <title>Strategies to prevent intraoperative lung injury during cardiopulmonary bypass  </title>
        <description>During open heart surgery the influence of a series of factors such as cardiopulmonary bypass (CPB), hypothermia, operation and anaesthesia, as well as medication and transfusion can cause a diffuse trauma in the lungs. This injury leads mostly to a postoperative interstitial pulmonary oedema and abnormal gas exchange. Substantial improvements in all of the above mentioned factors may lead to a better lung function postoperatively. By avoiding CPB, reducing its time, or by minimizing the extracorporeal surface area with the use of miniaturized circuits of CPB, beneficial effects on lung function are reported. In addition, replacement of circuit surface with biocompatible surfaces like heparin-coated, and material-independent sources of blood activation, a better postoperative lung function is observed. Meticulous myocardial protection by using hypothermia and cardioplegia methods during ischemia and reperfusion remain one of the cornerstones of postoperative lung function. The partial restoration of pulmonary artery perfusion during CPB possibly contributes to prevent pulmonary ischemia and lung dysfunction. Using medication such as corticosteroids and aprotinin, which protect the lungs during CPB, and leukocyte depletion filters for operations expected to exceed 90 minutes in CPB-time appear to be protective against the toxic impact of CPB in the lungs. The newer methods of ultrafiltration used to scavenge pro-inflammatory factors seem to be protective for the lung function. In a similar way, reducing the use of cardiotomy suction device, as well as the contact-time between free blood and pericardium, it is expected that the postoperative lung function will be improved.</description>
        <link>http://www.cardiothoracicsurgery.org/content/5/1/1</link>
                <dc:creator>Efstratios Apostolakis</dc:creator>
                <dc:creator>Efstratios Koletsis</dc:creator>
                <dc:creator>Nikolaos Baikoussis</dc:creator>
                <dc:creator>Stavros Siminelakis</dc:creator>
                <dc:creator>Georgios Papadopoulos</dc:creator>
                <dc:source>Journal of Cardiothoracic Surgery 2010, 5:1</dc:source>
        <dc:date>2010-01-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1749-8090-5-1</dc:identifier>
        <prism:publicationName>Journal of Cardiothoracic Surgery</prism:publicationName>
        <prism:issn>1749-8090</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
